Inactive Instrument

Immunosyn Corp Share Price

Equities

US45253Q1013

Pharmaceuticals

End-of-day quote Other OTC Other stock markets
- ^USD	-

on all our subscriptions*

Take advantage of the offer

* See conditions on site

Press releases Immunosyn Corp

IMMUNOSYN CORP COM STK USD0.0001 : Immunosyn Announces Proposed Agreements for Distribution of the Biopharmaceutical SF-1019 in Utah	16/08/16	PR
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Files 10-Q	17/08/17	PR
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Corporation Announces 2007 Results, Files 10KSB	01/08/01	PR
Immunosyn Corp Com Stk Usd0.0001 : Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019	26/08/26	PR
Immunosyn Corp Com Stk Usd0.0001 : Douglas A. McClain, Jr. Resumes CFO Duties at Immunosyn	02/08/02	PR

More press releases

Managers and Directors - Immunosyn Corp

Managers	Title	Age	Since
Stephen D. Ferrone CEO	Chief Executive Officer	73	15/07/15
Douglas A. McClain DFI	Director of Finance/CFO	49	-

Members of the board	Title	Age	Since
Douglas A. McClain DFI	Director of Finance/CFO	49	-
Stephen D. Ferrone CEO	Chief Executive Officer	73	15/07/15

Company Profile

Sector

Pharmaceuticals

More about the company

Sector Biopharmaceuticals

	1st Jan change	Capi.
CSL LIMITED	-2.61%	88.47B
SAMSUNG BIOLOGICS CO.,LTD.	+3.82%	40.71B
BIOGEN INC.	-13.92%	32.43B
UCB	+52.34%	24.28B
BIOMARIN PHARMACEUTICAL INC.	-15.25%	15.52B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-39.93%	12.17B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.08%	12B
INCYTE CORPORATION	-14.80%	12.01B
SWEDISH ORPHAN BIOVITRUM AB	+7.12%	8.87B

Biopharmaceuticals

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW